CAS: 1672665-49-4
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
PT-2385 REF: AN-AG00ABOZCAS: 1672665-49-4 | 98% | 67.00 €~575.00 € | Wed 08 May 24 | |
PT-2385 REF: TM-T7848CAS: 1672665-49-4 | 99.39% | 66.00 €~848.00 € | Wed 15 May 24 | |
PT2385 REF: 3D-XRC66549CAS: 1672665-49-4 | Min. 95% | To inquire | Thu 20 Jun 24 |
Ref: AN-AG00ABOZ
5mg | 67.00 € | |
10mg | 108.00 € | |
25mg | 175.00 € | |
50mg | 214.00 € | |
100mg | 479.00 € | |
250mg | 575.00 € |
Estimated delivery in United States, on Wednesday 8 May 2024
PT-2385
CAS:1672665-49-4
PT-2385 is a selective HIF-2α inhibitor (Kd<50 nM).
Formula:
C17H12F3NO4S
Purity:
99.39%
Color and Shape:
Solid
Molecular weight:
383.34
Ref: TM-T7848
1mg | 66.00 € | |
2mg | 96.00 € | |
5mg | 150.00 € | |
10mg | 253.00 € | |
25mg | 402.00 € | |
50mg | 596.00 € | |
100mg | 848.00 € | |
1ml*10 (DMSO) | 124.00 € |
Estimated delivery in United States, on Wednesday 15 May 2024
PT2385
CAS:1672665-49-4
PT2385 is a drug that has shown potent antitumor activity in animal models against renal …
Formula:
C17H12F3NO4S
Purity:
Min. 95%
Molecular weight:
383.34 g/mol
Ref: 3D-XRC66549
1mg | To inquire | |
5mg | To inquire | |
10mg | To inquire | |
25mg | To inquire | |
50mg | To inquire |
Estimated delivery in United States, on Thursday 20 Jun 2024